Gilead Sciences
Price & Volume
Stats
See moreOpen | $120.31 |
Previous Close | $120.47 |
Day Range | $119.71-$121.70 |
52W Range | $70.61-$121.38 |
Market Cap | $148.1B |
Shares Short | 22M |
Financials
See moreRevenue (12 Mos) | $28.8B |
Revenue Growth (YoY) | 1.8% |
Gross Profit (12 Mos) | $22.6B |
Diluted EPS | $5.04 |
News
See moreYahoo Finance • 3 hours ago
Gilead Sciences stock hits 52-week high at 121.67 USD
Yahoo Finance • 16 hours ago
Gilead Receives Favorable CHMP Opinion For HIV Prevention With Twice-Yearly Lenacapavir
Yahoo Finance • yesterday
Kymera Q2 2025 slides: Strong pipeline advances despite revenue decline
Yahoo Finance • yesterday
Validea Detailed Fundamental Analysis - GILD
About
CEO | Mr. Daniel P. O'Day |
Address | 333 Lakeside Drive, Foster City, CA, United States, 94404 |
Sector | Healthcare |
Industry | Drug Manufacturers - General |
Full-Time Employees | 17,600 |
